Pharmaceutical Industry to Help Excipients Sales in Latin America to Gain Remarkably, Forecasts Tmr

Transparency Market

Research

Excipients Market - Latin America Industry Analysis,

Size, Share, Growth, Trends, and Forecast 2015 - 2023

Published Date

10-May-2016

284 Page Report

Buy Now

Request Sample

Press Release

Pharmaceutical Industry to Help Excipients Sales in Latin America

to Gain Remarkably, forecasts TMR

Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

www.transparencymarketresearch.com

sales@transparencymarketresearch.com

Excipients Market

REPORT DESCRIPTION

Excipients Market - Latin America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 2023

The top three participants in the Latin America excipients market, Ashland Inc., BASF SE, and FMC

Corporation, hold a collective share of 26.2% in the market in 2014. Ashland Inc. will focus on restructuring its

global programs and integrating centralized supply chains for retaining its competitive edge in the overall

market, TMR expects. On the other hand, BASF SE and FMC Corporation are investing in result-driven

research and development to introduce effective products to their existing product portfolio.

In the coming years, in addition to catering to the pharmaceutical industry, the players in the Latin America

excipients market will expand the applications of their excipients to improve revenues, expects TMR.

Get FREE Sample Of This Report : http://www.transparencymarketresearch.com/sample/sample.php?

flag=S&rep_id=10883

Pharmaceutical Industry Backs Progress of Excipients Market

The Latin America excipients market is mainly being driven by the booming pharmaceuticals industry that uses

excipients as flavoring agents, binders, disintegrants agents for making tablets, capsules, and other forms of

drugs. The research states that the pharmaceutical industry in Latin America will progress at a CAGR of 8.1%

in terms of revenue between 2015 and 2023. The increasing population of geriatrics is acting as a fulcrum for

the pharmaceutical...